[1] 郭梅,赵一电,杨海军,等. 5406例不同类型食管肿瘤临床病理特征对比分析. 肿瘤防治研究,2008,15:54-56. [2] Tachibana M,Kinygasa S,Hirahara N,et al. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothorac Surg,2008,34:427-431. [3] Eloubeidi MA,Desmond R,Arguedas MR. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer,2002,95:1434-1443. [4] 冯庆来,尚淑艳,赵锡江. 胸段食管癌淋巴结转移规律的探讨. 中国肿瘤临床,2005,32:706-708. [5] 董芳莉,王瑾,郭梅,等. 食管癌淋巴结转移的临床病理因素. 中国肿瘤临床与康复,2003,10:316-318. [6] 王军,韩春,祝淑钗,等. 胸段食管癌淋巴结转移规律及其影响因素. 中国肿瘤临床,2010,37:75-78. [7] 李进东,王文光,许金良,等. 胸段食管癌淋巴结转移特点的研究. 中华医学杂志,2006,86:3197-3200. [8] Huang W,Li BS,Gong HY,et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol,2010,95:229-233. [9] Chen JQ,Liu SY,Pan JJ,et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg,2009,36:480-486. [10] 吴君旭,徐盛松,赵旭东,等. 胸段食管癌三区域淋巴结清扫术的临床应用. 安徽医学,2010,31:468-470. [11] 郑安平,冯连杰,张卫民,等. 988例食管癌野外淋巴结转移的研究. 中华放射肿瘤学杂志,1998,7:133-135. [12] Li HC,Zhang YW,Cai H,et al. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Eur Surg Res,2007,39:1-6. [13] Hulscher JB,van Sandick JW,Tijssen JG,et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg,2000,191:143-148. [14] Gotohda N,Nishimura M,Yoshida J,et al. The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus. Hepatogastroenterology,2005,52:105-107. [15] 柳硕岩,佘志廉,朱坤寿,等. 472例胸段食管癌行颈、胸、腹三野淋巴结清扫术的临床研究. 福建医药杂志,2005,27:38-40. [16] 刘巍,郝希山,陈勇,等. 1526例胸段食管癌及贲门癌淋巴结转移状况分析. 中国肿瘤临床,2008,35:601-605. [17] 姚沛旭,许建生,周旭文,等. 胸段食管癌术后淋巴结转移213例CT分析. 实用医学影像杂志,2008,9:225-227. [18] Tachimori Y,Nagai Y,Kanamori N,et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus,2011,24:33-38. [19] 陈俊强,佘志廉,潘建基,等. 胸段食管癌放疗靶区外淋巴结转移规律的研究. 中华肿瘤防治杂志,2007,14:1418-1421. [20] Kakegawa T,Fujita H,Yamana H. The Japanese and international stage classification of esophageal carcinoma. Surg Ther,1992,67:383-389. [21] Mariette C,Balon JM,Piessen G,et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer,2003,97:1616-1623. [22] Zhao KL,Ma JB,Liu G,et al. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys,2010,76:446-451. [23] Cooper JS,Guo MD,Herskovic A,et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial(RTOG 85-01). Radiation therapy oncology group. JAMA,1999,281:1623-1627. [24] Minsky BD,Pajak TF,Ginsberg RJ,et al. INT 0123(radiation therapy oncology group 94-05) phase Ⅲ trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol,2002,20:1167-1174. [25] Mei ZR,Xiang QC,Wu WJ,et al. Randomized controlled trial of prophylactic radiotherapy for postoperative esophageal carcinoma. Chin J Radiat Oncol,1997,6:188-189. [26] Ténière P,Hay JM,Fingerhut A,et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet,1991,173:123-130. [27] Fok M,Sham JS,Choy D,et al. Postoperative radiotherapy forcarcinoma of the esophagus: a prospective,randomized controlled
study. Surgery,1993,113:138-147. [28] Bédard EL,Inculet RI,Malthaner RA. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer,2001,91:2423-2430. [29] Nishimura Y,Ono K,Imamura M,et al. Postoperative radiation therapy for esophageal cancer. Radiat Med,1989,7:88-94. [30] Kato H,Tachimori Y,Watanabe H,et al. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol,1991,48:106-111. [31] Lerut T,Nafteux P,Moons J,et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging,diseasefree survival,and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg,2004,240:962-972. [32] Mandard AM,Chasle J,Marnay J,et al. Autopsy findings in 111 cases of esophageal cancer. Cancer,1981,48:329-335. [33] Xiao ZF,Yang ZY,Liang J,et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg,2003,75:331-336. [34] Yu E,Dar R,Rodrigues GB,et al. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients? Radiother Oncol,2004,73:141-148. [35] Lu JC,Tao H,Zhang YQ,et al. Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma. Dis Esophagus,2008,21:502-507. [36] 葛红,蒋月,刘劲松. 胸段食管鳞癌术后放疗靶区的确定.临床肿瘤学杂志,2005,10:526-527,544. [37] 刘祥. 胸段食管癌术后预防性放疗的价值及照射范围的探讨. 实用癌症杂志,2005,20:425-426. [38] Satoru N,Tatsuo K,Shinichi K,et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three field lymphadenectomy. Am Coll Surg,2004,198:205-211. [39] 陈俊强,陈明强,李云英,等. 胸段食管癌三野根治术后放疗靶区的临床研究. 中华放射医学与防护杂志,2006,26:374-377.
2012, Vol. 21 
